Delivery Order SPE2DB25D2203-SPE2DB25FPRSF

Award Date 4/7/25
Potential Completion Date 4/8/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,493.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of EUCRISA 2% ointment, a pharmaceutical product, with a completion date of April 2, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,201.67, is for the delivery of EUCRISA 2% ointment 60GM. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,152.59 firm fixed-price delivery order is for the supply of EUCRISA 2% ointment, a topical medication, with a performance period ending on May 20, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,343.33 delivery order contract is for the provision of EUCRISA 2% ointment 100GM, a prescription medication. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the procurement of EUCRISA 2% ointment in 60 gram units. The contract has a ceiling value of $7,363.51 and is a firm fixed price delivery order with a period of performance through March 27, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a prime vendor for the DLA, providing a wide range of medical...
This federal contract award (SPE2DB20D3505|SPE2DB24FT5B9) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,939.73 firm fixed-price delivery order is for the pharmaceutical product EUCRISA 2% Ointment 60GM. The contract has an ultimate completion date of December 26, 2023 and was awarded on December 22, 2023 with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, with an ID of SPE2DX15D7056|SPE2DX24F1UDE, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation for the delivery of EUCRISA 2% ointment in 60 gram tubes. The firm fixed price delivery order has a ceiling value of $1,341.26 and an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, is the prime...
This federal contract award, SPE2DX15D3402|SPE2DX25F1KDY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,487.36 firm fixed-price contract is for the delivery of EUCRISA 2% Ointment 60GM, a topical medication. The contract has an ultimate completion date of December 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EUCRISA 2% ointment 60GM. The contract has a ceiling value of $2,101.23 and a period of performance ending on July 9, 2025. AmerisourceBergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania. The company holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUCRISA 2% ointment, a prescription medication, with a ceiling value of $3,525.40 and a performance period through April 2025. The contract is not designated as a set-aside and represents an open competition award. AmerisourceBergen Drug Corp is the prime contractor, and...
  • SPE2DB25D2203
    Indefinite Delivery Contract
  • SPE2DB25D2203-SPE2DB25FPRSF
    Delivery Order

This federal contract award, valued at $1,746.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUCRISA 2% ointment in 60 gram quantities, with an ultimate completion date of April 8, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The current award is a delivery order issued under this larger IDC contract.

This contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and no subcontractors are mentioned. The DLA, a defense agency, is the funding agency for this award, which aligns with the company's role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 7/7/25, 1:23 PM